Jan 10 (Reuters) - Royalty Pharma (RPRX.O), opens new tab said on Friday it would pay about $1.1 billion to acquire RP Management, an organization that manages the healthcare firm's operations, as it ...
“The fluctuation of average annual rates, as well as the generally downward trend of the rates in Chart 3, may have reflected the structural changes in the licensing market since the enactment of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results